GGrantIndex
← Leaderboards

Eyal Raz

University Of California San Diego

$14,631,538
Attributed
$17,285,455
Total exposure
16
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,651,257 · 17

By mechanism

P01$9,719,990 · 5
R01$8,119,037 · 4
U01$5,709,652 · 3
R21$1,715,078 · 4
R56$387,500 · 1

Top collaborators

Most similar at University Of California San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingSignal TransductionPhenotypeGenesT-LymphocytePathway InteractionsInflammationResponseDendritic CellsIn VivoCellsPhysiologicalColitisInsightRegulationIn VitroInflammatoryCytokineImmune ResponseBaseCyclic AmpImmuneAdjuvantCd4 Positive T Lymphocytes

Grant awards (58)

Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never Smokers$619,804
U01 · FY2025 · CA · contact PI
Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never Smokers$588,218
U01 · FY2024 · CA · contact PI
Chronic Exposure to House Dust Mites: A New Risk Factor for Lung Cancer in Never Smokers$618,586
U01 · FY2023 · CA · contact PI
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC$719,797
R01 · FY2022 · HL · contact PI
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC$718,659
R01 · FY2021 · HL · contact PI
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC$717,520
R01 · FY2020 · HL · contact PI
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells$461,125
U01 · FY2020 · AI · contact PI
A novel pathway of Th17/Th2 induction: The role of cAMP signaling in DC$716,381
R01 · FY2019 · HL · contact PI
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells$461,125
U01 · FY2019 · AI · contact PI
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells$461,125
U01 · FY2018 · AI · contact PI
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells$461,125
U01 · FY2017 · AI · contact PI
Control of mucosal immunity by Gas- vs Gai-linked GPCR signaling in dendritic cells$461,125
U01 · FY2016 · AI · contact PI
The inductive role of Gs/Gi signaling in dendritic cell polarization and function$387,500
R56 · FY2015 · AI · contact PI
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa$301,556
U01 · FY2015 · AI · contact PI
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa$308,844
U01 · FY2014 · AI · contact PI
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa$315,918
U01 · FY2013 · AI · contact PI
Regulation of Mucosal Inflammation by Th17 Subsets$210,464
P01 · FY2013 · DK · contact PI
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa$322,788
U01 · FY2012 · AI · contact PI
Regulation of Mucosal Inflammation by Th17 Subsets$217,021
P01 · FY2012 · DK · contact PI
The diverse contribution of TLR pathways to intestinal homeostasis$371,372
R01 · FY2011 · AI · contact PI
Th17 subsets: Differential roles in immune defense mechanisms at the G-I mucosa$328,313
U01 · FY2011 · AI · contact PI
Regulation of Mucosal Inflammation by Th17 Subsets$186,463
P01 · FY2011 · DK · contact PI
The diverse contribution of TLR pathways to intestinal homeostasis$375,123
R01 · FY2010 · AI · contact PI
Mucosal adjuvants regulate inflammation and immunity$193,125
R21 · FY2010 · AI · contact PI
Regulation of Mucosal Inflammation by Th17 Subsets$188,348
P01 · FY2010 · DK · contact PI
The Impact of TLR on Intestinal Tumorigenesis$169,950
R21 · FY2010 · CA · contact PI
The diverse contribution of TLR pathways to intestinal homeostasis$378,911
R01 · FY2009 · AI · contact PI
Mucosal adjuvants regulate inflammation and immunity$231,750
R21 · FY2009 · AI · contact PI
Regulation of Mucosal Inflammation by Th17 Subsets$228,230
P01 · FY2009 · DK · contact PI
The Impact of TLR on Intestinal Tumorigenesis$203,940
R21 · FY2009 · CA · contact PI
TLR Ligand-Based Vaccines for SIV/HIV$446,556
R01 · FY2008 · AI · contact PI
The diverse contribution of TLR pathways to intestinal homeostasis$378,911
R01 · FY2008 · AI · contact PI
Mechanisms of CpG-Induced Inhibition of Allergic Asthma$242,899
R01 · FY2008 · AI · contact PI
TLR Ligand-Based Vaccines for SIV/HIV$441,835
R01 · FY2007 · AI · contact PI
The diverse contribution of TLR pathways to intestinal homeostasis$386,250
R01 · FY2007 · AI · contact PI
Mechanisms of CpG-Induced Inhibition of Allergic Asthma$240,394
R01 · FY2007 · AI · contact PI
Mucosal Immune Regulation By Bacterial DNA$197,439
P01 · FY2007 · DK · contact PI
Critical Analysis of the Hygiene Hypothesis$1,448,478
P01 · FY2006 · AI · contact PI
TLR Ligand-Based Vaccines for SIV/HIV$441,753
R01 · FY2006 · AI · contact PI
Mechanisms of CpG-Induced Inhibition of Allergic Asthma$240,363
R01 · FY2006 · AI · contact PI
Critical Analysis of the Hygiene Hypothesis$1,450,594
P01 · FY2005 · AI
TLR Ligand-Based Vaccines for SIV/HIV$439,137
R01 · FY2005 · AI
Mechanisms of CpG-Induced Inhibition of Allergic Asthma$237,821
R01 · FY2005 · AI
Mechanisms of Tolerance Induction by Immunostimulatory *$231,000
R21 · FY2005 · HL
TLR Ligand-Based Vaccines for SIV/HIV$42,600
R01 · FY2005 · AI
Critical Analysis of the Hygiene Hypothesis$1,415,991
P01 · FY2004 · AI
TLR Ligand-Based Vaccines for SIV/HIV$428,776
R01 · FY2004 · AI
Mechanisms of Tolerance Induction by Immunostimulatory *$230,250
R21 · FY2004 · HL
Mechanisms of CpG-Induced Inhibition of Allergic Asthma$153,979
R01 · FY2004 · AI
Critical Analysis of the Hygiene Hypothesis$1,377,953
P01 · FY2003 · AI
Critical Analysis of the Hygiene Hypothesis$742,358
P01 · FY2002 · AI
Hygiene Hypothesis: The Role of Innate Immunity$0
P01 · FY2002 · AI
ALLERGEN GENE VACCINATION--PRINCIPLES AND APPLICATIONS$825,740
P01 · FY2001 · AI
ISS AS AN ADJUVANT FOR SIV/HIV-BASED VACCINE$227,813
R21 · FY2001 · AI
ALLERGEN GENE VACCINATION--ANIMAL MODELS$0
P01 · FY2001 · AI
ALLERGEN GENE VACCINATION--PRINCIPLES AND APPLICATIONS$1,104,688
P01 · FY2000 · AI
ISS AS AN ADJUVANT FOR SIV/HIV-BASED VACCINE$227,250
R21 · FY2000 · AI
ALLERGEN GENE VACCINATION--ANIMAL MODELS$126,223
P01 · FY2000 · AI